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Abstract
Premature ovarian insufficiency (POI) is a clinical syndrome defined by a loss of ovarian activity before the age of 40. Its
pathogenesis is still largely unknown, but increasing evidences support a genetic basis in most cases. Among these,
20 heterozygous mutations in NOBOX, a homeobox gene encoding a transcription factor expressed specifically by oocyte and
granulosa cells within the ovary, have been reported in 6% of women with sporadic POI. The pivotal role of NOBOX in early
folliculogenesis is supported by findings in knock-out mice. Here, we report the genetic screening of 107 European women
with idiopathic POI, recruited in various settings, and the molecular and functional characterization of the identified variants
to evaluate their involvement in POI onset. Specifically, we report the identification of two novel and two recurrent heterozy-
25 gous NOBOX variants in 7 out of 107 patients, with a prevalence of 6.5% (upper 95% confidence limit of 11.17%). Furthermore,
immunolocalization, Western Blot and transcriptional assays conducted in either HEK293T or CHO cells revealed that all the
studied variants (p.R44L, p.G91W, p.G111R, p.G152R, p.K273*, p.R449* and p.D452N) display variable degrees of functional
impairment, including defects in transcriptional activity, autophagosomal degradation, nuclear localization or protein insta-
bility. Several variants conserve the ability to interact with FOXL2 in intracellular aggregates. Their inability to sustain gene
30 expression, together with their likely aberrant effects on protein stability and degradation, make the identified NOBOX
mutations a plausible cause of POI onset.
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Introduction
Premature ovarian insufficiency (POI) is a clinical syndrome de-
fined by a loss of ovarian activity occurring in about 1% of women
before the age of 40 (1), which is characterized by amenorrhea,
5 hypoestrogenism, and high gonadotropin levels. Furthermore, one
out of ten women aged between 40 and 45 suffers from early men-
opause (EM) (2). There are no currently available diagnostic tools to
promptly predict the onset of the disease, and oftentimes patients
are diagnosed when their oocyte reserve has already been severely
10 compromised and, with that, their chances of conceiving (3).
Although common causes of POI include cytogenetic abnormal-
ities of the X chromosome, as well as a history of endocrine auto-
immunity, such pathology remains classified as idiopathic in most
cases. A genetic basis for ovarian insufficiency is supported by the
15 fact that a substantial number of cases (4–31%) are family linked
(4,5), and so far an increasing number of genes have been identified
to be mutated in women with POI, each one of those explaining no
more than 3–6% of cases (6). Interestingly, some of those genes en-
code for transcription factors known to play pivotal roles in follicu-
20 lar physiology (7,8). One of those is the Newborn Ovary Homeobox
(NOBOX, OMIM *610934) transcription factor, a homeodomain-
containing, oocyte- and granulosa cell-specific protein (9,10) able to
directly regulate the expression of key oocyte-specific factors such
as Gdf9, Oct4 and KIT-L (11–14). In mice, NOBOX expression can be
25 detected in embryonic ovaries as early as embryonic day 15.5, and
its knock-out has been shown to cause female sterility due to ac-
celerated postnatal oocyte loss and blockade in the primordial to
primary follicle transition (11,15). Follicles are then replaced by fi-
brous tissue in female knockout mice in a manner similar to ovar-
30 ian dysgenesis in women (11). Further corroborating the
importance of NOBOX activity for folliculogenesis, heterozygous
NOBOX mutations have been consistently reported in women with
sporadic POI of African and Caucasian origin at a prevalence of 
6% (POF5, OMIM #611548) (14,16–19). Vice versa, mutations in the
35 homeobox domain of NOBOX seem not to be common explana-
tions for POI in Asian women (20,21). The aim of this study was to
expand the screening for NOBOX mutations to a new large cohort
of 107 unrelated women with sporadic POI and to evaluate the
functional impact of both our novel variants as well as several of
40 those previously reported, with the ultimate goal of better under-
standing the role of NOBOX mutations in the onset of Premature
Ovarian Insufficiency.
Results
Novel NOBOX variants have been identified in a cohort of
45 107 women with sporadic premature ovarian insufficiency
A total of 107 women of European origin affected with idiopathic
POI and with a normal 46,XX karyotype were included in this
study. Genetic analysis of the entire coding sequence and intron-
exon junctions of NOBOX identified three missense and one non-
50sense variants (see Table 1) in 7 patients of our series. The variants
c.331G>A (p.G111R) and c.1354G>A (p.D452N) were previously re-
ported (14,8,19), whereas variants c.454G>A (p.G152R) and
c.1345C>T (p.R449*) are novel. All the variants are located outside
the homeodomain, and were found in the heterozygous state.
55The frequencies of all the identified variants in the POI popu-
lation did not differ significantly from those reported in the
Exome Aggregation Consortium Browser (ExAC) (p> 0.05,
Fisher’s exact test).
Table 1 lists all the identified variants in relation to the clini-
60cal manifestation. Particularly, patients 2 and 3, carrying variant
p.G152R, both presented with a mild phenotype of EM, which
onsets respectively at 44 and 45 years old, with oligomenorrhea
starting from age 39 in the latter case. On the contrary, the earli-
est onset of the disease was in patient 7 (with primary amenor-
65rhea) and patient 4 who, despite having experienced
spontaneous menarche, was diagnosed with POI at age 14. The
remaining patients experienced secondary amenorrhea.
In silico analysis
The results of the in silico analysis to predict the functional im-
70pact of the two novel variants are summarized in Table 2.
Briefly, we used five different bioinformatic tools to predict their
possible impact on protein structure and function. The p.R449*
variant was predicted to be pathogenic with a high degree of
confidence by all softwares, while the p.G152R variant was pre-
75dicted to be damaging only by three of five tools.
POI-associated NOBOX variants impair
transcriptional activity
The functional consequences of the variants found in our co-
hort (p.G111R, p.G152R, p.R449* and p.D452N) were evaluated in
80HEK293T cells on the human OCT4 (Fig. 1) AQ2AQ34and GDF9 (data not
shown) promoters, both of which contain NOBOX binding ele-
ments. We observed a dramatic significant decrease in the
transactivation of both reporter genes upon co- transfection
with all the mutant constructs compared to the WT. Such re-
85sults were confirmed on both reporter genes in CHO cells
(Supplementary Material, Fig. S1).
POI-associated NOBOX variants impair nuclear
trafficking and solubility in HEK293T cells
As NOBOX transcriptional activity on its DNA targets relies on
90its translocation inside the nucleus, we then conducted
Table 1. Clinical evaluation of the seven POI patients












1 SA 26 c.331G>A Exon 4 p.G111R rs571490209 0.002 0.005 14
2 EM 44 c.454G>A Exon 4 p.G152R rs201806397 0.008 0.009 Novel
3 EM 45
4 SA 14 c.1345C>T Exon 8 p.R449a rs760393493 3.334e -05 0.005 Novel
5 SA NAa c.1354G>A Exon 8 p.D452N rs112190116 0.014 0.014 18
6 SA 40
7 PA –
aEM: Early Menopause; PA: Primary Amenorrhea; SA: Secondary Amenorrhea; NA: data Not Available.
bNCBI reference sequence: NM_001080413.3.
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immunolocalization experiments in HEK293T cells transiently
transfected with the NOBOX constructs WT and mutants
(p.G111R, p.G152R, p.R449* and p.D452N). We included in the
present study two previously reported variants: p.R44L, which
5 has been proposed as benign, and the POI-associated p.G91W
(14). As NOBOX belongs to a family of transcription factors inter-
acting with DNA through a homeodomain, the additional
p.K273* mutant (termed DHomeodomain), truncated at the level
of the DNA-binding homeodomain, was generated to be used as
10 a fully inactive control (10). In order to ensure the detection of
either strong or mild localization defects, confocal images were
acquired for all constructs and processed with an ImageJ macro
to quantify the nuclear-to-cytosolic eYFP signal ratio. As
NOBOX nuclear localization signal is contained in its homeodo-
15 main (9), the DHomeodomain mutant showed a complete im-
pairment in nuclear translocation compared to the WT. A
moderate defect in nuclear localization was assessed for all var-
iants (except for the p.R44L), but reached statistical significance
only in case of variants p.G91W, p.G152R and p.D452N (Fig. 2A
20 and B). Moreover, the p.G91W, p.G111R, p.G152R and p.D452N
mutants displayed a significant tendency to form both intranu-
clear and cytosolic aggregates, as shown by the quantification
in Fig. 2C and D. To assess whether the NOBOX protein mutants
sequestered inside the aggregates still retained the capacity to
25 interact with known NOBOX partners, the aggregation-prone
variants DHomeodomain, p.G91W, p.G111R, p.G152R and
p.D452N were cotransfected with a construct encoding for the
well-known NOBOX interactor FOXL2 (10) in HEK293T cells, and
their colocalization was evaluated with the ImageJ plugin
30 JACoP. Indeed, the aggregates formed by variants p.G91W,
p.G111R, p.G152R and p.D452N colocalized with FOXL2 punctate
staining in 13-27% of aggregates-containing cells, (see Table 3).
Such colocalization appears to be specific, as the aggregates
formed by the DHomeodomain variant, which lacks the binding
35 domain for FOXL2 (10), never co-localized with FOXL2 (see
Fig. 3A and B).
Immuno-localization experiment conducted in CHO cells
failed to detect any impairment in mutant NOBOX solubility or
translocation to the nucleus except for the DHomeodomain
40variant, which was significantly retained in the cytoplasm
(Supplementary Material, Fig. S2A and B).
In addition, we performed transcriptional assays using vari-
ants of NOBOX and wt FOXL2. All NOBOX variants do not exhibit
any activity and in the presence of FOXL2 this activity is not
45rescued confirming that FOXL2 is trapped in the aggregates
(see Fig. 3C).
POI-associated NOBOX variants alter protein stability
In order to clarify the molecular mechanisms responsible for
the abnormal subcellular localization and the aggregates forma-
50tion upon overexpression of NOBOX variants, the mutant pro-
teins behavior was compared to the WT by Western blot
experiments. In addition to a major band of the expected molec-
ular weight for the WT and mutant proteins (bands FL, R449*
and H in Fig. 3A), the anti-eYFP antibody recognized several
55smaller fragments, which were particularly evident in the case
of the p.R449*, in which  50% of the total eYFP-positive signal
is restricted to a fragment of the apparent size of 46 kDa (band
R449*-F1, see Fig. 3A and B). To assess whether such fragments
could be a byproduct of protein turnover, we assessed WT
60and mutant NOBOX degradation pattern by treating cells
with inhibitors of the two major proteolytic pathways, namely
the ubiquitin-proteasome and autophagosome-lysosomal
degradation.
Treatment with the proteasome inhibitor MG132 determined
65a strong increase in the signal of all eYFP-positive bands
(Fig. 3C). The increase in the truncated fragments signal was ac-
centuated in all the mutants compared to the WT protein, thus
evidencing a partial proteolytic cleavage especially in case of
variants p.R44L and p.G91W, which reached the statistical sig-
70nificance (see quantification in Fig. 3D).
Next, to investigate the potential role of lysosomal degrada-
tion in NOBOX clearance, we treated cells with NH4Cl, which in-
hibits all types of lysosomal proteolysis. The amount of WT,
p.G111R and p.G152R NOBOX mutants was increased by this
Table 2. In silico analysis of the NOBOX novel variants
Software Variant
p.G152R p.R449*
Polyphena Possibly Damaging (0.949) //
UMD Predictor b Polymorphism (32) Pathogenic (100)
Mut Tasterc Polymorphism (0,999) Disease causing (0,999)
SNPs&GOd Disease (1) //
SIFT/Proveane Deleterious (-2,983) Deleterious (-389,7)
ahttp://genetics.bwh.harvard.edu/pph2/. Scores range from 0 (benign variant) to
1 (damaging variant).
bhttp://umd-predictor.eu/. The pathogenicity scores are assigned as follows: a
value of less than 50 is associated with the prediction of a not pathogenic muta-
tion annotated as ‘‘polymorphism,’’ a value of 50 to 64 is associated with the
prediction of a ‘‘probable polymorphism,’’ a value of 65 to 74 is associated with
the prediction of a ‘‘probably pathogenic’’ mutation, while a value above 74 is
associated with the prediction of ‘‘pathogenic’’ mutation (38).
chttp://www.mutationtester.org/. A value close to 1 indicates a ‘high’ security of
the prediction.
dhttp://snps-and-go.biocomp.unibo.it/ The Reliability index has a range from 0
(unreliable) to 10 (reliable).
ehttp://sift.jcvi.org/. Variants are predicted to be deleterious if the score is below
-2.5; otherwise they are classified as neutral.
Figure 1. POI-associated NOBOX variants impair transcriptional activity. The
transcriptional activity of WT NOBOX, p.G111R, p.G152R, p.R449* and p.D452N
was studied with the use of OCT4 promoter transfected in HEK293T cells.
NOBOX activity is shown as the luciferase activity above baseline, which is de-
fined as the activity observed in transfection with empty vector. Results are pre-
sented as mean 6 s.e.m. of three independent experiments, each performed in
sixplicates. ****P< 0.0001, RLU, relative light units.
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Figure 2. POI-associated NOBOX variants impair nuclear trafficking and solubility. (A) Laser confocal microscopy of HEK293T cells transfected with eYFP-tagged WT
and mutant NOBOX (green). Nuclei were stained with DAPI (blue). For each transfectant, a representative merged image and the inverted green staining is shown. The
plot profiles from regions of interests crossing the nuclei (as wide as the merged image and 10 pixels tall) were obtained with NIH ImageJ Software. Bar, 10 mm. (B) Box
and Whiskers plot representing the nuclear-to-cytosolic NOBOX staining calculated from at least 90 cells from three different experiments for each transfectant. The
Tukey method was applied to identify outlier values. The red lines represent the median values. (C,D) Quantification of the percentage of cells showing eYFP-positive
aggregates (n> 90 cells from three different experiments from each transfectant) in the nucleus (N), cytoplasm (C) or both (NþC). P-values: $: P< 0.05; $$: P<0.01; $$$:
P< 0.001.
Table 3. In vitro features of NOBOX mutants
Features p.R44L p.G91W p.G111R p.G152R p.K273*a p.R449* D452N
Nuclear Localization Defects Strong Mild Yes Strong Mild Strong
No P< 0.01 n.s. P< 0.05 P< 0.001 n.s. P< 0.001
Intracellular Aggregates Strong Yes Yes Yes No Strong
No P< 0.001 P< 0.05 P< 0.05 P< 0.05 P< 0.01
Colocalization between aggregates and FOXL2 signal // Yes Yes Yes No // Yes
(26,7%)c (16,7%)c (13,3%)c (26,7%)c
Inhibition of FOXL2 transcriptional activity // // Yes Yes // Yes Yes
P< 0.01 P< 0.01 P< 0.01 P< 0.01
Appearance of Degradation Fragments (on WB) Strong Yes Mild Mild Strong Strong Variable
P< 0.01 P< 0.05 n.s. n.s. P< 0.01 P< 0.01
Autophagosomal Degradation Impairmentb Yes Yes Variable No Variable Yes Yes
Defective Transcriptional Activity No Yes Yes Yes Yes Yes Yes
n.s.: not significant.
aDHomeodomain.
bThe scores were assigned as follow: Yes, resistance to both rapamycin autophagy induction and NH4Cl mediated blockage; No, sensitivity to both rapamycin autoph-
agy induction and NH4Cl mediated blockage; Variable, discordant results between rapamycin and NH4Cl treatments.
cThe reported values (%) represent the percentage of NOBOX aggregates-bearing cells in which the colocalization between NOBOX aggregates and FOXL2 punctuate
staining (calculated by Manders colocalization coefficiency) was> 5%. Data obtained from at least 30 cells from two different experiments for each transfectant.
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treatment, suggesting that they are sensitive to lysosomal deg-
radation. On the other hand, the p.R44L, p.G91W, p.R449* and
p.D452N mutants were unaffected by NH4Cl, unraveling a po-
tential defect in their degradation (see blots and quantifications
5 in Fig. 4A and B).
Since NH4Cl treatment inhibits all types of lysosomal prote-
olysis (i.e. macroautophagy, microautophagy or chaperone-
mediated autophagy), we further specifically investigated the
involvement of macroautophagy by treating cells with the
10 blocker 3-methyladenine (3-MA) (22). 3-MA treatment strongly
impaired degradation of all NOBOX constructs, without any sig-
nificant differences among WT and mutants (Fig. 4C and D).
Treatment with autophagy-inducer rapamycin further deter-
mined a significant decrement in the amount of WT and
15 p.G152R full-length bands, thus suggesting the involvement of
autophagy in their degradation. Variants p.G91W, p.G111R and
p.D452N, while partially resistant to rapamycin treatment,
showed a significant decrease of the full-length bands upon
starvation. On the contrary, variants p.R44L and p.R449* showed
20insensitivity to both autophagy inducers (Fig. 4E and F). The
autophagosomal system appears to play a role only on full-
length NOBOX clearance, as we saw no effects on the intensity
of the intermediate fragments upon treatment with either
NH4Cl, 3-MA, rapamycin or starvation (Fig. 4A, C and E). While a
25more in depth analysis of NOBOX degradation patterns would
broaden our knowledge on NOBOX turnover, such experiments
are beyond the scope of this study.
Discussion
NOBOX is a transcription factor expressed in oocytes and granu-
30losa cells with a fundamental role in primordial follicle
Figure 3. NOBOX aggregation-prone variants colocalize with FOXL2 in HEK293T cells. (A) Laser confocal microscopy of HEK293T cells co-transfected with eYFP-tagged
NOBOX aggregation-prone variants (green) and V5-tagged FOXL2 (red). The constructs transfected in each images are indicated on the left. Nuclei were stained with
DAPI (blue). For each transfectant, two representative merged images and 2X magnifications of the boxed areas are shown. The 2X magnifications represent the indi-
vidual stainings for the eYFP (green) and V5 (red) signals, as well as the colocalization signal (yellow) obtained with NIH ImageJ function ‘Image Calculator’. Bar: 10 mm.
(B) Dot plot representing the percentage of colocalisation between the NOBOX signal localized in aggregates and the punctuate FOXL2 signal measured by
Manders’colocalisation coefficient in 30 cells from two different experiments for each transfectant. Each single dot in the graph represents a cell. (C) The transcriptional
activity of WT NOBOX, p.G111R, p.G152R, p.R449* and p.D452N was studied with the use of OCT4 promoter transfected in HEK293T cells. NOBOX activity is shown as
the luciferase activity above baseline, which is defined as the activity observed in transfection with empty vector. Results are presented as mean 6 s.e.m. of three inde-
pendent experiments, each performed in sixplicates. **P< 0.01. ctl, control; RLU, relative light units.
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formation and primordial to primary follicle transition during
ovarian folliculogenesis (11,15). In this study, we identified two
known mutations (p.G111R and p.D452N) and two new variants,
the missense mutation p.G152R and the nonsense mutation
5 p.R449*, in a cohort of 107 European 46,XX women with POI,
with a prevalence of 6.5% and an upper 95% confidence limit of
11.17%.
As the in silico analysis gave contrasting results, we carried
out the molecular and functional characterization of these vari-
10 ants, as well as of four previously reported ones (p.R44L,
p.G91W, p.G111R and p.D452N) (results summarized in Table 3).
The first experiments were aimed at the evaluation of the
functional impact on transcriptional activity of the mutants in
HEK293T cells, and revealed a total loss of transactivation on
15 both OCT4 and GDF9 promoters for all variants found in our pa-
tients, including the already published, but never in vitro tested
p.D452N mutation. The immunolocalization experiments on
eYFP-tagged WT and mutant NOBOX in HEK293T cells further
revealed an impaired nuclear localization for all variants, except
20 for the p.R44L, which has already been proposed to represent a
rare benign variant with a mild functional impact (14). This lo-
calization failure is associated with the appearance of intracel-
lular aggregates in the case of variants p.G91W, p.G111R,
p.G152R and p.D452N. As intracellular aggregates are usually
25 degraded via autophagic pathways that converge on the lyso-
some, we treated cells with autophagy modulators such as
NH4Cl, 3-MA, rapamycin or serum starvation, which collectively
demonstrated that WT NOBOX could be degraded via autophagy
in HEK293T cells, which has never been reported in literature
30before. Concerning the aggregation-prone variants, the p.G91W
and p.D452N displayed a significant degradation impairment
compared to WT. This finding suggests that these aggregates
are not degraded by autophagy process. Since NOBOX activity
relies on its dimerization and all mutations were detected in the
35heterozygous state, the formation of these aggregates could be
of particular interest for the POI pathology, as a higher tendency
of the mutant proteins to aggregate may not only hamper their
translocation to the nucleus, but may also lead to a partial se-
questration of the wild-type counterpart. Such deleterious ef-
40fect may be further worsened by the sequestration of additional
NOBOX interactors into the aggregates, as indicated by the fact
that the protein aggregates formed by NOBOX variants p.G91W,
p.G111R, p.G152R and p.D452N colocalized with the known
NOBOX interactor FOXL2 (10) upon cotransfection. The exis-
45tence of a physical interaction in these cytoplasmic aggregates
is supported by the conserved inhibition of FOXL2 wild-type
transcriptional activity by the NOBOX variants (see Fig. 3).
Interestingly, solubility defects have already been reported for
variants of FOXL2 itself (24), whose mutations are also associ-
50ated with POI (25).
Noteworthy, protein aggregation and cleavage defects have
been reported to be implicated in ageing as well as in the onset
of several degenerative pathologies (e.g. neurodegenerative dis-
eases), where the formation of aggregates enhance the toxic ef-
55fect of the mutant proteins (25). It is therefore not surprising
that similar pathogenic mechanisms may be implicated in the
Figure 4. POI-associated NOBOX variants alter protein stability. (A,B) A representative Western blot of HEK293T cells transiently transfected with the indicated eYFP-
tagged NOBOX constructs. The M16 empty vector was transfected as control (MOCK). The densitometric quantification of the relative abundance of NOBOX fragments
in each transfectant is shown in panel B. Data are the mean 6 s.e.m. of three indepenent experiments. The colored asterisks represent the statistical significance of
WT vs mutants among the following groups: black for ‘Full Length construct’; blue for ‘Other fragments’ and green for ‘eYFP fragment’. (C,D) Representative immuno-
blot and densitometric quantification of the relative abundance of NOBOX fragments in each transfectant after treatment with 10 mM MG132 for 16 h prior to lysis.
Twenty mg of protein lysates were loaded onto each lane. P-values: *P< 0.05; **P <0.01; ***P< 0.001.
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onset of POI, which may be considered as an accelerated ovar-
ian ageing (26,27).
Degradation defects in the absence of aggregates were also
seen for variant p.R449*. However, the impact of this nonsense
5 mutation in vivo may be more complex, as it could either lead to
the translation of a truncated protein devoid of biological activ-
ity or, given the position of the c.1345C>T transition in respect
to the immature NOBOX mRNA, perhaps the trigger mutant
mRNA degradation through nonsense-mediated RNA decay and
10 ultimately lead to a haploinsufficency (28). Similarly, since all
the NOBOX variants identified in our patients are in the hetero-
zygous state, possible interactions could occur between wild-
type and mutant proteins in vivo.
In contrast to the effects on mutant protein localization ob-
15served in HEK293T, we failed to detect any defect in mutants’
trafficking in the epithelial cell line derived from the ovary of
the Chinese hamster (CHO cells). However, it is widely known
that nuclear permeability can be finely regulated by modulating
the expression of the nuclear transport factors (29). In this re-
20gard, CHO cells might be more permissive to NOBOX nuclear
Figure 5. POI-associated NOBOX variants alter protein clearance via autophagy.AQ8 (A–F) Representative immunoblots and relative densitometric quantifications (ex-
pressed as ratios between treated and untreated) of HEK293T cells transfected with eYFP-tagged NOBOX constructs and treated with either 10 mM NH4Cl (A,B), 10 mM
3-MA (C,D), 1 lM Rapamycin or serum starved (E,F) for 24 h prior to lysis. The P-values were calculated either versus WT (B,D) or versus the ‘Untreated’ of each transfec-
tant (F). The M16 empty vector was transfected as control (MOCK). (A–F) Twenty mg of protein lysates were loaded onto each lane except for 3-MA-treated cells (C), for
which 10 mg were loaded. Actin (ACT) was probed as a loading control. P-values: *P< 0.05; **P<0.01; ***P< 0.001.
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trafficking, thus preventing the detection of any defect in the
mutants’ translocation efficiency. In line with this hypothesis,
unlike HEK293T, nuclear import of the wild-type protein itself
seemed to be more efficient in CHO cells, whose nuclei never
5 appeared completely devoid of NOBOX signal (see comparison
between Fig. 2A and Supplementary Material, S2A). Such obser-
vation suggests the intriguing possibility that not only NOBOX
expression but also its localization inside the cell may have a
role in follicle differentiation, as already suggested for transcrip-
10 tion factors involved in spermatogenesis (30). Indeed, the im-
portance of the nuclear import system for follicle development
has already been suggested by the fact that a missense muta-
tion in the nuclear pore complex factor NUP-107 has been asso-
ciated with 46,XX gonadal dysgenesis (31). Nevertheless, the
15 striking impairment in mutant NOBOX transactivational capac-
ity was confirmed in CHO cells. In vitro studies previously per-
formed on two of the aggregation-prone variants p.G91W and p.
G111R demonstrated the inhibition of transcriptional activity
due to their absent DNA binding (14). Alternatively, the lack of
20 reporter activation capacity in the absence of evidences of pro-
tein mislocalization and aggregation could be triggered either
by the alteration of protein stability or by the loss of potential
interaction with other factors through steric or electrostatic ef-
fects, a frequent phenomenon accounting for up to 80% of
25 disease-associated aminoacid substitutions (32,33).
In our study, the phenotype of patients carrying the same
mutation was often discordant, making it difficult to draw a
clear genotype-phenotype correlation. For example, variant
p.D452N remains of uncertain significance, since it displayed
30 multiple defects in in vitro tests (see Table 3) despite being found
with the same allele frequency in the ExAC browser. Moreover,
heterozygous NOBOX p.D452N carriers manifested various de-
grees of ovarian dysfunction, ranging from primary to second-
ary amenorrhea. This lack of a correlation between genotype
35 and the severity of the clinical manifestation has already been
described in POI in case of some BMP15 mutations (34) as well
as for NOBOX itself (14), thus strongly corroborating a model of
complex pathogenesis (35) with variable penetrance in which
one or more concurring variations in other predisposing gene or
40 genes may further worsen the phenotype leading to an earlier
disease onset, as recently shown by Bouilly and colleagues (19).
In contrast, the variant p.G152R displays a milder and more
consistent phenotype, with both carriers affected by EM. The
milder phenotype of the carriers is also in line with the forma-
45 tion of aggregates in the absence of degradation defects we saw
in in vitro tests.
Overall, we show that the NOBOX variants p.G111R, p.G152R,
p.R449* and p.D452N identified in our POI patients have an aber-
rant activity in in vitro tests. Their inability to sustain gene ex-
50 pression, together with the likely deleterious effects of protein
aggregation, which may cause protein sequestration and defec-
tive degradation, makes them a plausible cause of POI onset in
women with POI. Our data add to the mounting evidence sup-
porting the importance of NOBOX activity in ovarian follicle
55 physiology and further strengthens the need for geneticists
working on POI to consider NOBOX screening a priority.
Materials and Methods
Patients and controls
A total of 107 women affected by idiopathic POI were included in
60 this study. All the patients received a diagnosis of Premature
Ovarian Insufficiency on the basis of the presence of amenorrhea
for a period more than 6 months before the age of 40 years,
together with two distinct measurements of plasmatic FSH lev-
els in the postmenopausal range. All selected patients had a nor-
65mal karyotype. Genetic investigation was extended to a cohort of
141 controls from the general population of the same ethnicity
(84 females and 57 males). Institutional ethical committees ap-
proved the study, and informed consent for blood sampling and
genetic investigations were obtained from all participants.
70DNA sequencing
Genomic DNA was isolated from leukocytes of peripheral blood
by using an automatic DNA extractor Tecan Freedom Evo (Tecan
Group Ltd, M€annedorf, Switzerland). Next generation sequencing
of NOBOX entire coding sequence (i.e. exons 1-10) and intron-
75exon junctions was performed on 95 out of 107 by using miSeq
instrument (Illumina, San Diego, CA, USA). Direct sequencing
was also performed in the remaining cases. Reference sequences
were obtained from NCBI (reference sequence: NM_001080413.3).
Constructs
80The plasmid encoding V5-tagged FOXL2 has been described else-
where (36). The eYFP-tagged plasmid encoding full-length hu-
man NOBOX (Ensembl database accession #ENST00000467773)
was purchased from Genecopoeia (Rockville, MD, USA). The mis-
sense mutants p.R44L, p.G91W, p.G111R, p.G152R, p.D452N were
85obtained by site directed mutagenesis using the Agilent Quick-
change II site-mutagenesis kit (Agilent Technologies, Santa
Clara, CA, USA) starting from the wild-type (WT) construct. The
non-sense variants DHomeodomain and p.R449*, as well as the
M16-MOCK plasmid were obtained by subcloning from the origi-
90nal plasmid. All of the plasmid sequences were verified by
means of direct sequencing to exclude unwanted substitutions.
Cell culture and transfection
HEK293T or CHO cells were cultured in DMEM (Dulbecco’s
Modified Eagle Medium)þGlutamax (Thermo Fisher Scientific,
95Waltham, MA, USA) supplemented with 1% penicillin-
streptomycin and 10% foetal bovine serum (all from Sigma
Aldrich, Saint Louis, MO, USA) at 37 C and 5% CO2, and tran-
siently transfected using Fugene HD (Promega, Madison, WI,
USA) according to the manufacturer’s protocol.
100Treatments
Autophagy and proteasome inhibitors were used at the follow-
ing final concentrations: 10 mM MG132 (M7449, Sigma Aldrich),
10 mM NH4Cl (A5666, Sigma Aldrich) and 10 mM 3-MA (M9281,
Sigma Aldrich). Twenty-four hours after transfection, HEK293T
105cells were cultured for additional 24 h in OptimemþGlutamax
(Thermo Fisher Scientific) with 1% FBS and supplemented with
the indicated inhibitors. Twenty-four hours after transfection,
HEK293T cells were cultured for additional 24 h with the
autophagy inducer rapamycin (R8781, Sigma Aldrich) at 1lM
110concentration in DMEMþGlutamax. Serum starvation was per-
formed 24 h after transfection by incubating HEK293T cells in
DMEM (Thermo Fisher Scientific) for additional 24 h.
Immunoblotting
Cell extracts were solubilized in sodium dodecyl sulphate dena-
115turation buffer. Equal amounts of extracted proteins were
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separated on NuPage 4–12% BIS-TRIS gels (Thermo Fisher
Scientific) and transferred onto nitrocellulose membranes
(Thermo Fisher Scientific). Commercial primary antibodies were
anti-actin (BD Biosciences, San Jose, CA, USA) and an anti-GFP
5 against a common GFP/YFP epitope (Sigma Aldrich; listed as
anti-YFP in the Results section), which we used to detect YFP-
tagged constructs. Peroxidase-conjugated anti-mouse IgG
(Thermo Fisher Scientific) was used as secondary reagent, and
signals were visualized by means of an ECL Western blotting de-
10 tection system (Millipore, Billerica, MA, USA). The densitometric
quantification of signal intensities was performed by using the
NIH ImageJ Software (NIH, Bethesda, MA, USA).
Reporter assays
The cells were cotransfected in 96-well plates by using FuGENE
15 6 (Promega), according to the manufacturer’s protocol with
40 ng of NOBOX vector, 60 ng of promoter report vector, and
50 ng of the control vector containing Renilla luciferase, pRL-TK
(Promega). Cells were lysed 48 h later with 1X passive lysis buf-
fer (Promega). Firefly and Renilla luciferase activities were mea-
20 sured consecutively by using dual-luciferase assays (Promega)
and a TriStar reader (Berthold, Bad Wildbad, Germany) and are
expressed as relative light units (RLU). Each value is the average
of six biological replicates, and each experiment shown is repre-
sentative of at least five independent experiments.
25 HEK293T cells or CHO cells were transfected 48h with firefly
luciferase promoter reporters (OCT4 or GDF9 or DK3 promoters),
renilla vector, NOBOX and/or FOXL2 expression vectors or
pcDNA3.1 vectors as control, as previously done (10,14).
Immunofluorescence microscopy
30 Forty-eight hours after transfection, HEK293T or CHO cells were
fixed with 4% paraformaldehyde and mounted using ProLong Gold
Antifade reagent (Thermo Fischer Scientific) containing DAPI for
nuclei staining. For co-transfection experiments, HEK293T cells
were fixed as described, stained with anti-V5 antibody (Novus
35 Biologicals, Littleton, CO, USA) followed by goat anti-mouse Alexa
Fluor 555 secondary antibody (Invitrogen Molecular Probes), and
mounted with ProLong Gold Antifade reagent. Images were ac-
quired using a Nikon EclipseTi-E inverted microscope with IMA10X
Argon-ion laser System by Melles Griot (Nikon, Tokyo, Japan); all
40 images were acquired with CFI Plan Apo VC 60X Oil (Nikon).
Image Analysis
Plot profiles in Fig. 2A were obtained using NIH ImageJ Software
plot profile. The black and white images in Fig. 2A were obtained
by inverting the signal of the green channel using Adobe
45 Photoshop (Adobe Systems, San Jose, CA, USA).
To quantify the nuclear-to-cytosolic eYFP signal in NOBOX-
transfected HEK293T or CHO cells, confocal images were pro-
cessed with an ImageJ macro we generated as follows: briefly, the
DAPI signal was processed with an automatic threshold to obtain
50 a ‘NUCLEUS’ mask that we applied on the green channel to iso-
late the nuclear NOBOX signal. The green channel was also
thresholded to isolate the whole NOBOX-positive cell. Nuclear
and cell areas and total signal intensities were measured. For
each cell, the signal ratio between the mean of nuclear and cyto-
55 solic eYFP signals was then calculated. At least 90 cells from three
different experiments were analysed for each transfectant in
case of HEK293T cells. For CHO cells, 60 cells from two different
experiments were analysed for each transfectant.
The immunofluorescence images of HEK293T cells were also
60analysed for the appearance of intracellular aggregates by man-
ually assessing at least 90 cells form three different experiments
for each transfectant.
The magnifications showing the colocalization signal only in
Fig. 3A was obtained with NIH ImageJ function ‘Image
65Calculator’, using the ‘MIN’ operation. To quantify NOBOX-FOXL2
colocalization, confocal images of HEK293T cells positive for both
FOXL2 signal and NOBOX-positive aggregates were processed as
follows: for each cell, the percentage of colocalisation between
the NOBOX variant and FOXL2 inside the aggregates was ob-
70tained by calculating the Manders’ colocalisation coefficient us-
ing ImageJ plugin JACoP (37). The thresholds for each image were
modified manually to exclude the soluble cytosolic signal from
the measurements. The signal from the nuclei was also excluded
from the quantification. At least 30 cells from two different ex-
75periments were analysed for each transfectant.
Statistical Analysis
All quantitative data are presented as mean6 s.e.m (standard
error of the mean). Each quartile value used to draw the box and
whisker plot (Fig. 3B) represents itself the mean of at least three
80independent experiments. Multiple comparisons among groups
were carried out by two-tailed Student’s t-test, and in particular
the Tukey Method was applied to identify outlier values in Fig.
2B, using GraphPad Prism software (GraphPad Software Inc., La
Jolla, CA, USA). Statistical significance was indicated as follow:
85*P< 0.05, **P< 0.01, ***P< 0.001 and ****P< 0.0001.
Fisher’s exact test was used in the analysis of a 22 contin-
gency table reporting the allelic frequencies among groups (POI
patients and ExAC European controls).
The upper 95% confidence limit for the proportion 7 out of
90107 patients with POI has been calculated by using the Stats
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Acknowledgements
The authors would like to thank the POI patients and the control
subjects who participated in this study and all the Clinical and
Academic Hospitals providing samples.
100Conflict of interest statement. None declared. AQ7
Funding AQ6
This work was supported by the Italian Health Ministry [GR-
2011-02351636 to R.R.], and the IRCCS Istituto Auxologico
Italiano [Ricerca Corrente Funds: 05C001_2010 to L.P.].
105References AQ5
1. ESHRE Guideline Group on POI, Webber, L., Davies, M.,
Anderson, R., Bartlett, J., Braat, D., Cartwright, B., Cifkova, R.,
de Muinck Keizer-Schrama, S., Hogervorst, E., et al. (2016)
ESHRE Guideline: management of women with premature
110ovarian insufficiency. Hum. Reprod., 31, 926–937. AQ9
9Human Molecular Genetics, 2016, Vol. xx, No. xx |
J_ID: HMG Customer A_ID: DDW342 Copyedited by: PR Manuscript Category: General Article Cadmus Art: OP-HMGJ
2. Pelosi, E., Forabosco, A. and Schlessinger, D. (2015) Genetics
of the ovarian reserve. Front. Genet., 6, 308.
3. Shelling, A.N. (2010) Premature ovarian failure. Reproduction,
140, 633–641.
5 4. Persani, L., Rossetti, R. and Cacciatore, C. (2010) Genes in-
volved in human premature ovarian failure. J. Mol.
Endocrinol., 45, 257–279.
5. Chapman, C., Cree, L. and Shelling, A.N. (2015) The genetics
of premature ovarian failure: current perspectives. Int. J.
10 Womens Health, 7, 799–810.
6. Qin, Y., Jiao, X., Simpson, J.L. and Chen, Z.J. (2015) Genetics of
primary ovarian insufficiency: new developments and op-
portunities. Hum. Reprod. Update, 21, 787–808.
7. Jagarlamudi, K. and Rajkovic, A. (2012) Oogenesis: transcrip-
15 tional regulators and mouse models. Mol. Cell Endocrinol.,
356, 31–39.
8. Lim, E.J. and Choi, Y. (2012) Transcription factors in the
maintenance and survival of primordial follicles. Clin. Exp.
Reprod. Med., 39, 127–131.
20 9. Suzumori, N., Yan, C., Matzuk, M.M. and Rajkovic, A. (2002)
Nobox is a homeobox-encoding gene preferentially ex-
pressed in primordial and growing oocytes. Mech. Dev., 111,
137–141.
10. Bouilly, J., Veitia, R.A. and Binart, N. (2014) NOBOX is a key
25 FOXL2 partner involved in ovarian folliculogenesis. J. Mol.
Cell Biol., 6, 175–177.
11. Rajkovic, A., Pangas, S.A., Ballow, D., Suzumori, N. and
Matzuk, M.M. (2004) NOBOX deficiency disrupts early follicu-
logenesis and oocyte-specific gene expression. Science, 305,
30 1157–1159.
12. Choi, Y. and Rajkovic, A. (2006) Characterization of NOBOX
DNA binding specificity and its regulation of Gdf9 and
Pou5f1 promoters. J. Biol. Chem., 281, 35747–35756.
13. Bayne, R.A., Kinnell, H.L., Coutts, S.M., He, J., Childs, A.J. and
35 Anderson, R.A. (2015) GDF9 is transiently expressed in oo-
cytes before follicle formation in the human fetal ovary and
is regulated by a novel NOBOX transcript. PLoS One, 10,
e0119819.
14. Bouilly, J., Roucher-Boulez, F., Gompel, A., Bry-Gauillard, H.,
40 Azibi, K., Beldjord, C., Dode´, C., Bouligand, J., Mantel, A.G.,
He´cart, A.C., et al. (2015) New NOBOX mutations identified in
a large cohort of women with primary ovarian insufficiency
decrease KIT-L expression. J. Clin. Endocrinol. Metab., 100,
994–1001.
45 15. Lechowska, A., Bilinski, S., Choi, Y., Shin, Y., Kloc, M. and
Rajkovic, A. (2011) Premature ovarian failure in nobox-
deficient mice is caused by defects in somatic cell invasion
and germ cell cyst breakdown. J. Assist. Reprod. Genet., 28,
583–589.
50 16. Qin, Y., Choi, Y., Zhao, H., Simpson, J.L., Chen, Z.J. and
Rajkovic, A. (2007) NOBOX homeobox mutation causes pre-
mature ovarian failure. Am. J. Hum. Genet., 81, 576–581.
17. Bouilly, J., Bachelot, A., Broutin, I., Touraine, P. and Binart, N.
(2011) Novel NOBOX loss-of-function mutations account for
55 6.2% of cases in a large primary ovarian insufficiency cohort.
Hum. Mutat., 32, 1108–1113.
18. Bouali, N., Francou, B., Bouligand, J., Lakhal, B., Malek, I.,
Kammoun, M., Warszawski, J., Mougou, S., Saad, A. and
Guiochon-Mantel, A. (2016) NOBOX is a strong autosomal
60 candidate gene in Tunisian patients with primary ovarian
insufficiency. Clin. Genet., 89, 608–613.
19. Bouilly, J., Beau, I., Barraud, S., Bernard, V., Azibi, K., Fagart,
J., Fe`vre, A., Todeschini, A.L., Veitia, R.A., Beldjord, C., et al.
(2016) Identification of multiple gene mutations accounts for
65a new genetic architecture of primary ovarian insufficiency.
J. Clin. Endocrinol. Metab.:jc20162152.
20. Zhao, X.X., Suzumori, N., Yamaguchi, M.,. and Suzumori, K.
(2005) Mutational analysis of the homeobox region of the hu-
man NOBOX gene in Japanese women who exhibit prema-
70ture ovarian failure. Fertil. Steril., 83, 1843–1844.
21. Qin, Y., Shi, Y., Zhao, Y., Carson, S.A., Simpson, J.L. and
Chen, Z.J. (2009) Mutation analysis of NOBOX homeodomain
in Chinese women with premature ovarian failure. Fertil.
Steril., 91, 1507–1509.
7522. Vakifahmetoglu-Norberg, H., Xia, H.G. and Yuan, J. (2015)
Pharmacologic agents targeting autophagy. J. Clin. Invest.,
125, 5–13.
23. Caburet, S., Demarez, A., Moumne´, L., Fellous, M., De Baere,
E. and Veitia, R.A. (2004) A recurrent polyalanine expansion
80in the transcription factor FOXL2 induces extensive nuclear
and cytoplasmic protein aggregation. J. Med. Genet., 41,
932–936.
24. Verdin, H. and De Baere, E. (2012) FOXL2 impairment in hu-
man disease. Horm. Res. Paediatr., 77, 2–11.
8525. Labbadia, J. and Morimoto, R.I. (2015) The biology of proteo-
stasis in aging and disease. Annu. Rev. Biochem., 84, 435–464.
26. Gagnon, A., Smith, K.R., Tremblay, M., Ve´zina, H., Pare´, P.P.
and Desjardins, B. (2009) Is there a trade-off between fertility
and longevity? A comparative study of women from three
90large historical databases accounting for mortality selection.
Am. J. Hum. Biol., 21, 533–540.
27. Cedars, M.I. (2013) Biomarkers of ovarian reserve-do they
predict somatic aging?. Semin. Reprod., 31, 443–451.
28. Ottens, F. and Gehring, N.H. (2016) Physiological and patho-
95physiological role of nonsense-mediated mRNA decay.
Pflugers Arch., 468, 1013–1028.
29. Yasuhara, N., Oka, M. and Yoneda, Y. (2009) The role of the
nuclear transport system in cell differentiation. Semin. Cell.
Dev. Biol., 20, 590–599.
10030. Hogarth, C.A., Calanni, S., Jans, D.A. and Loveland, K.L. (2006)
Importin a mRNAs have distinct expression profiles during
spermatogenesis. Dev. Dyn., 235, 253–262.
31. Weinberg-Shukron, A., Renbaum, P., Kalifa, R., Zeligson, S.,
Ben-Neriah, Z., Dreifuss, A., Abu-Rayyan, A., Maatuk, N.,
105Fardian, N., Rekler, D., et al. (2015) A mutation in the
nucleoporin-107 gene causes XX gonadal dysgenesis. J Clin
Invest., 125, 4295–4304.
32. Schuste, B. and Bateman, A. (2008) Protein interactions in
human genetic diseases. Genome Biol., 9, R9.
11033. Yue, P., Li, Z. and Moult, J.J. (2005) Loss of protein structure
stability as a major causative factor in monogenic disease.
Mol. Biol., 353, 459–473.
34. Rossetti, R., Di Pasquale, E., Marozzi, A., Bione, S., Toniolo, D.,
Grammatico, P., Nelson, L.M., Beck-Peccoz, P. and Persani, L.
115(2009) BMP15 mutations associated with primary ovarian in-
sufficiency cause a defective production of bioactive protein.
Hum. Mutat., 30, 804–810.
35. Toniolo, D. (2006) X-linked premature ovarian failure: a com-
plex disease. Curr. Opin. Genet. Dev., 16, 293–300.
12036. Georges, A., Benayoun, B.A., Marongiu, M., Dipietromaria, A.,
L’Hoˆte, D., Todeschini, A.L., Auer, J., Crisponi, L. and Veitia,
R.A. (2011) SUMOylation of the Forkhead transcription factor
10 | Human Molecular Genetics, 2016, Vol. xx, No. xx
J_ID: HMG Customer A_ID: DDW342 Copyedited by: PR Manuscript Category: General Article Cadmus Art: OP-HMGJ
FOXL2 promotes its stabilization/activation through tran-
sient recruitment to PML bodies. PLoS One, 6, e25463.
37. Bolte, S. and Cordelie`res, F.P. (2006) A guided tour into sub-
cellular colocalization analysis in light microscopy. J.
5 Microsc., 224, 213–232.
38. Fre´de´ric, M.Y., Lalande, M., Boileau, C., Hamroun, D.,
Claustres, M., Be´roud, C. and Collod-Be´roud, G. (2009) UMD-
predictor, a new prediction tool for nucleotide substitution
pathogenicity – application to four genes: FBN1, FBN2,
10TGFBR1, and TGFBR2. Hum. Mutat., 30, 952–959.
11Human Molecular Genetics, 2016, Vol. xx, No. xx |
